Ysabel Ilagan-Ying, MD
Hospital Resident
Research & Publications
Biography
News
Coauthors
Selected Publications
- Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system.Ilagan-Ying YC, Xu J, Lim JK, Do A. Low real-world eligibility rates for nonalcoholic steatohepatitis patients for phase 3 clinical trial criteria application in a large academic health system. European Journal Of Gastroenterology & Hepatology 2021, 33: 424-429. PMID: 32433419, PMCID: PMC7674230, DOI: 10.1097/MEG.0000000000001758.
- Analysis of weekend effect in severe acute liver injury: A nationwide database study.Do A, Ilagan-Ying YC, Taddei TH. Analysis of weekend effect in severe acute liver injury: A nationwide database study. Health Science Reports 2020, 3: e139. PMID: 32166187, PMCID: PMC7060892, DOI: 10.1002/hsr2.139.
- Unilateral leg pain caused by cryptococcal myositis: An unusual presentation of disseminated cryptococcosis in a kidney transplant recipient.Lier AJ, Virmani S, Ilagan-Ying Y, Leelatian N, Darbinyan A, Malinis M. Unilateral leg pain caused by cryptococcal myositis: An unusual presentation of disseminated cryptococcosis in a kidney transplant recipient. Transplant Infectious Disease : An Official Journal Of The Transplantation Society 2021, 23: e13491. PMID: 33040432, DOI: 10.1111/tid.13491.
- Medical Approach for Weight Loss in Nonalcoholic Fatty Liver DiseaseDo, A, Ilagan-Ying, YC & Mehal, WZ Medical Approach for Weight Loss in Nonalcoholic Fatty Liver Disease. Current Hepatology 2019, 18:444–454.
- Bisphenol-A exposure in utero programs a sexually dimorphic estrogenic state of hepatic metabolic gene expression.Ilagan Y, Mamillapalli R, Goetz TG, Kayani J, Taylor HS. Bisphenol-A exposure in utero programs a sexually dimorphic estrogenic state of hepatic metabolic gene expression. Reproductive Toxicology (Elmsford, N.Y.) 2017, 71: 84-94. PMID: 28476547, DOI: 10.1016/j.reprotox.2017.05.001.
- Bisphenol A (BPA) Exposure In Utero Leads to Immunoregulatory Cytokine Dysregulation in the Mouse Mammary Gland: A Potential Mechanism Programming Breast Cancer Risk.Fischer C, Mamillapalli R, Goetz LG, Jorgenson E, Ilagan Y, Taylor HS. Bisphenol A (BPA) Exposure In Utero Leads to Immunoregulatory Cytokine Dysregulation in the Mouse Mammary Gland: A Potential Mechanism Programming Breast Cancer Risk. Hormones & Cancer 2016, 7: 241-51. PMID: 26911702, DOI: 10.1007/s12672-016-0254-5.
- Altered genome-wide methylation in endometriosis.Naqvi H, Ilagan Y, Krikun G, Taylor HS. Altered genome-wide methylation in endometriosis. Reproductive Sciences (Thousand Oaks, Calif.) 2014, 21: 1237-43. PMID: 24784717, PMCID: PMC5933183, DOI: 10.1177/1933719114532841.
- Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints.Do A, Ilagan-Ying YC, Mehal WZ, Lim JK. Drug development of nonalcoholic fatty liver disease: challenges in research, regulatory pathways, and study endpoints. Expert Opinion On Drug Discovery 2021, 16: 125-134. PMID: 33086894, DOI: 10.1080/17460441.2020.1811674.
- Increased Mortality in Patients Undergoing Inpatient Endoscopy During the Early COVID-19 Pandemic.Ilagan-Ying YC, Almeida MN, Kahler-Quesada A, Ying L, Hughes ML, Do A, Hung KW. Increased Mortality in Patients Undergoing Inpatient Endoscopy During the Early COVID-19 Pandemic. Digestive Diseases And Sciences 2022 PMID: 35182250, PMCID: PMC8857390, DOI: 10.1007/s10620-022-07414-x.
- Pancreatic Neuroendocrine Tumor Presenting with Chylous Ascites: Multidisciplinary Workup to Differentiate from Malignant Ascites.Ilagan-Ying YC, Park EY, Lam R, Gupta S. Pancreatic Neuroendocrine Tumor Presenting with Chylous Ascites: Multidisciplinary Workup to Differentiate from Malignant Ascites. Journal Of General Internal Medicine 2022, 37: 2082-2085. PMID: 35260958, DOI: 10.1007/s11606-022-07463-y.